Skip to content

Effects of propofol intravenous infusion on nausea and vomit reactions of tramadol during resuscitation period after general anesthesia

Effects of propofol intravenous infusion on nausea and vomit reactions of tramadol during resuscitation period after general anesthesia

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032222
Enrollment
Unknown
Registered
2020-04-23
Start date
2020-05-01
Completion date
Unknown
Last updated
2020-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nausea and vomit

Interventions

control group:normal saline

Sponsors

Department of Anesthesiology, Nanjing Jinling Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients voluntarily sign the informed consent for this study; 2. Patients aged over 18 to 65 years old underwent elective general anesthesia for laparoscopic hysterectomy; 3. Patients weighing 50-65kg; 4. Patients undergoing elective laparoscopic hysterectomy; 5. Patients independently request analgesia before administration; 6. With no allergic disease, no constitution, no history of drug allergy, no history of non-malignant hyperthermia.

Exclusion criteria

Exclusion criteria: 1. Patients who have recently used monoamine oxidase inhibitors, opioids or psychoactive drugs; 2. With history of allergy to tramadol or propofol; 3. With history of epilepsy; 4. With hepatic or renal insufficiency; 5. Patients undergoing liver or kidney surgery; 6. Patients with heart valve disease or coronary artery abnormality; 7. With history of cerebral apoplexy; 8. With coagulation dysfunction; 9. With hypotension or shock; 10. With moderate to severe pulmonary dysfunction; 11. Preoperative pulse oxygen saturation (SPO2) below 90; 12. Pregnant or lactating women; Or subjects who had a pregnancy plan within 1 month after the trial (male subjects included); 13. Patients who had participated in the drug trial within 3 months prior to the trial (including the drugs in the trial); 14. Those who are deemed unfit to participate in the experiment by the anesthesiologist; 15. The researchers think there is any reason not to be included.

Design outcomes

Primary

MeasureTime frame
nausea;

Secondary

MeasureTime frame
vomit;OAA/S;numerical rating scale, NRS;Adverse events;

Countries

China

Contacts

Public ContactLi Renqi

Jinling Hospital, Jinling Clinical College, Nanjing Medical University

CSLBQRL@163.com+86 13451835080

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026